Identification of cisplatin-regulated metabolic pathways in pluripotent stem cells.
The chemotherapeutic compound, cisplatin causes various kinds of DNA lesions but also triggers other pertubations, such as ER and oxidative stress. We and others have shown that treatment of pluripotent stem cells with cisplatin causes a plethora of transcriptional and post-translational alterations...
Guardado en:
Autores principales: | Louise von Stechow, Ainhoa Ruiz-Aracama, Bob van de Water, Ad Peijnenburg, Erik Danen, Arjen Lommen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/790b6b9894b74c379669e034e7c6175f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The mTOR Pathway in Pluripotent Stem Cells: Lessons for Understanding Cancer Cell Dormancy
por: Bashar A. Alhasan, et al.
Publicado: (2021) -
Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells
por: Stephan Riesenberg, et al.
Publicado: (2018) -
Modeling preeclampsia using human induced pluripotent stem cells
por: Mariko Horii, et al.
Publicado: (2021) -
Induced pluripotent stem cells: advances to applications
por: Timothy J Nelson, et al.
Publicado: (2009) -
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma.
por: Alboukadel Kassambara, et al.
Publicado: (2012)